Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
BOVINE HERPES VIRUS TYPE 1 STRAIN DIFIVAC
Zoetis Ireland Limited
QI02AA03
BOVINE HERPES VIRUS TYPE 1 STRAIN DIFIVAC
Unknown
Suspension for Injection
POM(E)
Bovine
Bovine rhinotracheitis virus vaccine (IBR)
Immunological - Inactivated vaccine
Authorised
2013-12-09
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rispoval IBR-Marker Inactivated 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Suspension for injection. Pinkish liquid suspension, which might contain loose sediment. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. One dose (2 ml) contains: ACTIVE SUBSTANCE: Bovine Herpes Virus type 1 (BoHV-1), strain Difivac (gE-negative), to induce a geometric mean seroneutralizing titre of at least 1:160 in cattle ADJUVANT(S): Aluminium hydroxide 14-24 mg Quil A 0.25 mg EXCIPIENTS: _Preservative_ Thiomersal 0.20 mg For a full list of excipients see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 02/09/2015_ _CRN 7019769_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of cattle against Infectious Bovine Rhinotracheitis (IBR), to reduce the clinical signs and virus shedding and, in female cattle, to prevent abortions associated with BoHV-1 infection. The vaccination of pregnant cattle will prevent abortion associated with BoHV-1 infections as demonstrated during the second trimester of gestation upon challenge 28 days after vaccination. Vaccinated cattle can be differentiated from field virus infected animals due to the marker deletion, unless the cattle were previously vaccinated with a conventional vaccine or infected with field virus. Duration of immunity: 6 months - For booster immunisation after primovaccination with Rispoval IBR-Marker Live (in member states where this product is authorized) to reduce the virus shedding and the clinical signs associated with BoHV-1 infection in cattle and, in female cattle, to prevent abortions associated with BoHV-1 Pročitajte cijeli dokument